Larvol Delta - Centessa-Pharmaceuticals-Announces-NonHuman-Primate-Pharmacokinetic-and-Safety-Data-for-LB101-PDL1xCD47-Demonstrating-Potential-for-Enhanced-Therapeutic-Index

LB101 - Centessa

https://www.globenewswire.com/news-release/2022/09/12/2513845/0/en/Centessa-Pharmaceuticals-Announces-Non-Human-Primate-Pharmacokinetic-and-Safety-Data-for-LB101-PD-L1xCD47-Demonstrating-Potential-for-Enhanced-Therapeutic-Index.html

Sep 12, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next